Corvus Pharmaceuticals Inc (CRVS)
1.92
+0.19
(+10.98%)
USD |
NASDAQ |
May 03, 16:00
2.05
+0.13
(+6.77%)
After-Hours: 20:00
Corvus Pharmaceuticals Total Liabilities (Quarterly): 6.869M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.869M |
| September 30, 2023 | 7.653M |
| June 30, 2023 | 8.558M |
| March 31, 2023 | 9.33M |
| December 31, 2022 | 12.12M |
| September 30, 2022 | 15.67M |
| June 30, 2022 | 12.16M |
| March 31, 2022 | 11.57M |
| December 31, 2021 | 12.29M |
| September 30, 2021 | 14.18M |
| June 30, 2021 | 12.99M |
| March 31, 2021 | 14.85M |
| December 31, 2020 | 13.38M |
| September 30, 2020 | 13.51M |
| June 30, 2020 | 13.34M |
| March 31, 2020 | 13.76M |
| December 31, 2019 | 12.54M |
| Date | Value |
|---|---|
| September 30, 2019 | 12.06M |
| June 30, 2019 | 13.46M |
| March 31, 2019 | 11.61M |
| December 31, 2018 | 7.896M |
| September 30, 2018 | 8.375M |
| June 30, 2018 | 10.52M |
| March 31, 2018 | 11.46M |
| December 31, 2017 | 9.94M |
| September 30, 2017 | 11.05M |
| June 30, 2017 | 10.70M |
| March 31, 2017 | 8.876M |
| December 31, 2016 | 7.349M |
| September 30, 2016 | 6.853M |
| June 30, 2016 | 4.953M |
| March 31, 2016 | 4.674M |
| December 31, 2015 | 129.56M |
| September 30, 2015 | 126.94M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.869M
Minimum
Dec 2023
15.67M
Maximum
Sep 2022
12.12M
Average
12.54M
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.198M |
| Arbutus Biopharma Corp | 38.38M |
| Oragenics Inc | 1.798M |
| Relmada Therapeutics Inc | 12.19M |
| MAIA Biotechnology Inc | 7.089M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.55M |
| Shareholders Equity (Quarterly) | 38.68M |